Methylation Status of Alu and LINE-1 Interspersed Repetitive Sequences in Behcet’s Disease Patients

Table 1

Patient demographics and medications.

	Group	Age	Sex	Disease score	Medications	Active extraocular findings	Total extraocular findings	Active/inactive uveitis
1	Inactive	32	M	0	Interferon Alpha 2a (3 million) every other day	—	OA, GU, folliculitis, pathergy positivity, and joint involvement	Inactive
2	Inactive	25	F	0	Cyclosporine-A 150 mg/day and Azathioprine 100 mg	—	OA, GU, and EN	Inactive
4	Inactive	27	M	0	Infliximab infusions (5 mg /kg) at 0, 2, and 6 and then every 4–8 weeks was administered	—	OA, GU, and folliculitis	Inactive
5	Inactive	41	M	0	Cyclosporine 2.5 mg/kg/day, Azathioprine 100 mg/day	—	OA, GU, EN, and joint involvement	Inactive
6	Inactive	37	F	0	Interferon Alpha 2a (3 million) every other day	—	OA, GU, EN, folliculitis, pathergy positivity, and joint involvement	Inactive
7	Inactive	33	M	0	Azathioprine 100 mg/day	—	OA, GU, folliculitis, pathergy positivity, joint involvement, vascular involvement, and neurological involvement	Inactive
8	Inactive	41	M	0	Cyclosporine-A 2.5 mg/kg/day, Azathioprine 100 mg/day	—	OA, folliculitis, and pathergy positivity	Inactive
9	Inactive	40	F	0	Unmedicated	—	OA, GU, folliculitis, and pathergy positivity	Inactive
10	Inactive	57	M	0	Unmedicated	—	OA, GU, EN, joint involvement, and vascular involvement	Inactive
11	Inactive	26	M	0	Cyclosporine-A 2.5 mg/kg/day, Azathioprine 100 mg/day	—	OA, GU, EN, folliculitis, and joint involvement	Inactive
12	Inactive	21	F	3	Unmedicated	OA	OA, GU, EN, and folliculitis	Inactive
13	Inactive	46	M	0	Cyclosporine-A 2.5 mg/kg/day, Azathioprine 100 mg/day	—	OA, GU	Inactive
16	Inactive	34	F	0	Unmedicated	—	OA, GU, EN, pathergy positivity, and joint involvement	Inactive
17	Inactive	54	M	0	Azathioprine 100 mg/day	—	OA, GU, EN, folliculitis, joint involvement, vascular involvement, and neurological involvement	Inactive
18	Inactive	40	M	0	Cyclosporine-A 2.5 mg/kg/day, Azathioprine 100 mg/day	—	OA, GU, EN, and joint involvement	Inactive
19	Inactive	35	M	0	Interferon Alpha 2a (3 million) every other day	—	OA, GU, and pathergy positivity	Inactive
20	Inactive	36	M	0	Interferon Alpha 2a (3 million) every other day	—	OA, GU, EN, pathergy positivity, joint involvement, and vascular involvement	Inactive
1	Active	46	M	7	Interferon Alpha 2a (3 million) every other day	OA, GE	OA, GU, EN, pathergy positivity, and vascular involvement	Active U
2	Active	33	M	8	Interferon Alpha 2a (3 million) every other day	OA, GU, EN	OA, GU, pathergy positivity, EN, and joint involvement	Active
3	Active	21	M	7	Interferon Alpha 2a (3 million) every other day	OA, PP	OA, GU, EN, pathergy positivity, and joint involvement	Active
4	Active	31	M	7	Cyclosporine-A 2.5 mg/kg/day, Azathioprine 100 mg/day	OA, PP	OA, GU, folliculitis, and pathergy positivity	Active
5	Active	30	M	7	Interferon Alpha 2a (3 million) every other day	OA, PP	OA, GU, EN, folliculitis, pathergy positivity, joint involvement, and neurological involvement	Active
6	Active	37	F	7	Interferon Alpha 2a (3 million) every other day	OA, PP	OA, GU, EN, folliculitis, and joint involvement,	Active
7	Active	49	F	5	Cyclosporine-A 2.5 mg/kg/day, Azathioprine 100 mg/day	OA	OA, GU, EN, folliculitis, pathergy positivity, and joint involvement	Active
8	Active	18	F	5	Interferon Alpha 2a (3 million) every other day	OA	OA, GU, and EN	Active
9	Active	31	M	7	Interferon alpha 2a (3 Million) every other day	OA, PP	OA, GU, folliculitis, pathology positivity, and vascular involvement	Active
10	Active	34	M	5	Cyclosporine-A 2.5 mg/kg/day, Azathioprine 100 mg/day	OA	OA, PP, and Joint involvement	Active U
11	Active	27	F	7	Interferon Alpha 2a (3 million) every other day	OA, GU	OA, GU	Active U
12	Active	38	M	9	Cyclosporine-A 2.5 mg/kg/day, Azathioprine 100 mg/day	OA	OA, GU, folliculitis, and GI	Active U

F: female; M: male
U: Uveitis; OA: oral ulcers; GU: genital ulcers; EN: erythema nodosum; GI: gastrointestinal involv.